Share

News about the EORTC Liaison Offices in the United Kingdom and in France

This month a new UK-based EORTC Liaison Officer, Liz Flackett (e.flackett[at]ncrn.org.uk), joined the EORTC Liaison Office in the UK. This Office is jointly supported by the EORTC, the National Cancer Research Network (NCRN) and Cancer Research UK (CRUK) has taken her position. In June, a Liaison Office in France will be set up in partnership between the EORTC and the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

These Liaison Offices are aimed at fostering collaborative clinical cancer research between the EORTC and other international cancer research organisations and also supporting EORTC members in order to facilitate administrative and regulatory aspects of conducting EORTC trials.

Back to news list

Related News

  • EORTC calls for a balanced and feasible European Health Data Space (EHDS)

  • Professor Benjamin Besse becomes President of EORTC

  • CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

  • EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials

  • New study confirms a key quality of life tool can be used with adolescents with cancer

  • “Changing practice, improving lives”: EORTC publishes its Annual Report 2025

  • This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research

  • Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer

  • Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

  • EORTC’s presence at ESTRO 2026